Resumen
Guillain-Barre syndrome (GBS) is the most common and most severe
acute paralytic neuropathy with an annual incidence of 0.5 to 2 per
100, 000 inhabitants. It can affect people of all ages, but it is more
frequent in adults and in males [1,2]. The specific cause of GBS is still
unknown; however, its development is associated with previous respiratory
or gastrointestinal infections or another pathology in which
the immune system attacks the peripheral nerves [2]. GBS has no cure,
but an adequate treatment can improve symptoms and shorten its
duration (more than 90% of patients can recover completely one year
after the onset of the disease); whereas few cases are fatal (mortality
rate of 3–7%) [2,3].